Diabetes drugs with rosiglitazone are now available only through certified mail-order pharmacies. Doctors wishing to prescribe the drugs and patients planning to continue taking them should enroll in GlaxoSmithKline’s Avandia Rosiglitazone Medicines Access Program. As of November 18, Avandia (rosiglitazone maleate), Avandamet (rosiglitazone maleate and metformin hydrochloride), and Avandaryl (rosiglitazone …
Read More »Yearly Archives: 2011
Intensive Type 1 Diabetes Therapy Lowers Kidney Failure Risk by 50 Percent
Intensive therapy for type 1 diabetes mellitus lowers the long-term risk for impaired glomerular filtration rate (GFR).…
Read More »New Possible DPP-4/TZD Combo for Jan 2012
Takeda announced that the FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 25, 2012 for the review of its investigational type 2 diabetes therapy alogliptin, and the fixed-dose combination therapy alogliptin/pioglitazone.…
Read More »Poor Glucose Control Ups Mortality in Diabetes Patients on Dialysis
Poor glycemic control, whether too high or too low, is associated with decreased survival in diabetic patients on hemodialysis….
Read More »Sugary Drinks Tied to CVD Risk Factors Just for Women
Women who regularly drink sugary beverages may be increasing their cardiovascular risk….
Read More »Resveratrol Improves Metabolism in Obese Men
Resveratrol, an ingredient found in red wine, may improve the health of obese men….
Read More »Pig Transplant Boosts Diabetes Hopes
A pig’s pancreatic islets were transplanted into a diabetic monkey which was then administered a newly developed immune-regulating antibody. As a result, the monkey’s blood-sugar level was automatically controlled without any rejection, and has been healthy for the last six months….
Read More »Commercial Disease Management Programs are Ineffective
Commercial disease management models did not reduce hospital admissions or emergency room visits, or result in cost savings in a study of nearly 250,000 Medicare patients.…
Read More »FDA Recommends Vytorin for CVD Prevention in Predialysis CKD Patients
An FDA advisory committee has recommended unanimously that the ezetimibe-simvastatin combination pill (Vytorin) be approved for prevention of cardiovascular disease in CKD patients who are not on dialysis.…
Read More »New Study Supports Cardiovascular Safety of Bristol-Myers Squibb/AstraZeneca’s SGLT2 Drug Dapagliflozin in Type 2’s
Dapagliflozin, an inhibitor of SGLT2 as an adjunct to diet and exercise, is being investigated to evaluate its safety and its efficacy on blood sugar levels in adults with type 2 diabetes….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.